TY - JOUR
T1 - Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease
T2 - time for a high-definition picture?
AU - Piccari, Lucilla
AU - Bernardo, Roberto J.
AU - Rodríguez-Chiaradía, Diego
AU - Vitulo, Patrizio
AU - Wort, S. John
AU - Sahay, Sandeep
N1 - Funding Information:
S.S.: Consultancy fees from Janssen Pharmaceutical Companies of Johnson & Johnson, United Therapeutics, Bayer Pharmaceuticals; research/grant support from Chest Foundation (ILD research grant); Scientific medical advisor fees for United Therapeutics, Altavant Sciences, and Liquidia; and Speaker’s bureau fees from Janssen Pharmaceutical Companies of Johnson & Johnson, Bayer, and United Therapeutics.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/5/12
Y1 - 2021/5/12
UR - http://www.scopus.com/inward/record.url?scp=85107019364&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107019364&partnerID=8YFLogxK
U2 - 10.1177/20458940211018074
DO - 10.1177/20458940211018074
M3 - Letter
AN - SCOPUS:85107019364
SN - 2045-8932
VL - 11
JO - Pulmonary Circulation
JF - Pulmonary Circulation
IS - 2
ER -